XML 38 R27.htm IDEA: XBRL DOCUMENT v3.25.0.1

Derivative Financial Instruments (Tables)

6 Months Ended

Dec. 28, 2024

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Fair Value of Derivative Instruments in Consolidated Balance Sheets

The following table summarizes the fair value of the derivative instruments in the Consolidated Balance Sheets as of December 28, 2024 and December 30, 2023 (in thousands):

Fair Value

Derivatives designated as hedging instruments under Subtopic 815-20

Balance Sheet Location

December 28, 2024

June 29, 2024

Foreign currency forward contracts

Other current liabilities

$

1,306

$

277

Schedule of Gain (Loss) of Derivative Instruments in Statement of Operations

The following tables summarize the gain (loss) on derivative instruments, net of tax, on the Consolidated Statements of Operations for the three months ended December 28, 2024 and December 30, 2023, respectively (in thousands):

Derivatives Designated as Hedging Instruments			Classification of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)						AOCI Balance as of September 28, 2024						Effective Portion Recorded In AOCI						Effective Portion Reclassified From AOCI Into Income						AOCI Balance as of December 28, 2024
Forward contracts			Cost of sales						$	1,053					$	(543)					$	501					$	1,011
Total									$	1,053					$	(543)					$	501					$	1,011
Derivatives Designated as Hedging Instruments			Classification of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)						AOCI Balance as of September 30, 2023						Effective Portion Recorded In AOCI						Effective Portion Reclassified From AOCI Into Income						AOCI Balance as of December 30, 2023
Forward contracts			Cost of sales						$	—					$	263					$	(72)					$	191
Interest rate swap			Interest expense						(39)						—						39						—
Total									$	(39)					$	263					$	(33)					$	191

The following tables summarize the gain (loss) on derivative instruments, net of tax, on the Consolidated Statements of Operations for the six months ended December 28, 2024 and December 30, 2023, respectively (in thousands):

Derivatives Designated as Hedging Instruments			Classification of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)						AOCI Balance as of June 29, 2024						Effective Portion Recorded In AOCI						Effective Portion Reclassified From AOCI Into Income						AOCI Balance as of December 28, 2024
Forward contracts			Cost of sales						$	215					$	(2)					$	798					$	1,011
Total									$	215					$	(2)					$	798					$	1,011
Derivatives Designated as Hedging Instruments			Classification of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)						AOCI Balance as of July 1, 2023						Effective Portion Recorded In AOCI						Effective Portion Reclassified From AOCI Into Income						AOCI Balance as of December 30, 2023
Forward contracts			Cost of sales						$	—					$	263					$	(72)					$	191
Interest rate swap			Interest expense						(97)						—						97						—
Total									$	(97)					$	263					$	25					$	191

X

- References

No definition available.

+ Details

Name:	us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4E
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4E

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4C
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4C

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4A
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A

+ Details

Name:	us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4B

+ Details

Name:	us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration